Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Liberty Live-C
LLYVK
5
American Express
AXP
AU Stock MarketDetailed Quotes
ALA Arovella Therapeutics Ltd
- 0.083
- -0.002-2.35%
20min DelayTrading May 8 14:19 AET
98.26MMarket Cap-9.22P/E (Static)
0.086High0.083Low898.56KVolume0.086Open0.085Pre Close76.42KTurnover0.21052wk High0.10%Turnover Ratio1.18BShares0.06852wk Low-0.006EPS TTM73.89MFloat Cap360.698Historical HighLossP/E (Static)890.23MShs Float0.020Historical Low-0.009EPS LYR3.53%Amplitude--Dividend TTM8.30P/B1Lot Size--Div YieldTTM
About Arovella Therapeutics Ltd Company
Arovella Therapeutics Ltd is a biotechnology company focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumours. The company's lead iNKT cell product is ALA-101. ALA-101 consists of iNKT cells engineered to produce a Chimeric Antigen Receptor (CAR) targeting CD19 on their surface. This CD19-targeting CAR allows the iNKT cells to find and kill tumour cells that express CD19.
Company Profile
SymbolALA
Company NameArovella Therapeutics Ltd
Founded1999
MarketASX
Employees14
Fiscal Year Ends06-30
Address84 Hotham Street Corporate One
CityPreston
CountryAustralia
Zip Code3072
Phone+61 398636472
Websitehttps://www.arovella.com
Share RegistryAUTOMIC REGISTRY SERVICES
Suite 5, Level 12, 530 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
1300 288 664
Company Executives
- Name
- Position
- Salary
- Michael Baker
- Chief Executive Officer,Managing Director
- --
- Thomas (Tom) Duthy
- Non-Executive Chairman,Non-Executive Director
- --
- Gary Phillips
- Non-Executive Director
- --
- Elizabeth Stoner
- Non-Executive Director
- --
- Debora Barton
- Non-Executive Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting